Evolva Archives

In Depth 11 Jun 2020

How the Biotech Industry Makes Flavors Healthy and Eco-Friendly

The food industry is under pressure to create products that don’t just taste great, but that are also good for our health and for the environment. Biotechnology is emerging as a solution to enjoy the flavors we love without damaging our bodies or nature. We’ve been adding flavor to our food since ancient times. Throughout […]

June 11, 2020 - 9 minutesmins - By Clara Rodríguez Fernández

Infographics 21 Jun 2017

Check Out these 42 European SynBio Startups Reimagining the Industry

Synthetic biology, or synbio for short, is rapidly infiltrating multiple fields. From bioplastics to food technology and healthcare, these are the startups in Europe that are expanding the frontiers of what synbio can do to improve our lives in many different ways. In the not-so-distant future, synthetic biology could bring us anything from spider silk […]

June 21, 2017 - 1 minutemin - By Clara Rodríguez Fernández

News and Trends 8 Nov 2016

Swiss SynBio adds CRISPR to its Toolkit for new Specialty Chemicals

Evolva is licensing the CRISPR patents of Emmanuelle Charpentier, in a deal with holding company ERS Genomics. This will grant access to the wonder gene-editing technology for one of the most important players in European SynBio. Headquartered in Switzerland, Evolva develops new ways to obtain ingredients and specialty chemicals with brewing and engineered microorganisms. Its […]

November 8, 2016 - 2 minutesmins - By Denise Neves Gameiro

nootkatone evolva natural mosquito repellant zika

News and Trends 27 Jul 2016

SynBio Nootkatone now in trials to stop the Spread of Zika

The grapefruit aroma nootkatone is now in field trials to assess its effectiveness against mosquitoes that spread the Zika virus. Good news for Evolva, which figured out a SynBio process to produce the compound. Recently, the Zika went from being considered a mild virus to a public health emergency. As the virus was linked with infant microcephaly, there […]

July 27, 2016 - 3 minutesmins - By Denise Neves Gameiro

evolva us navy composite material synbio

News and Trends 14 Apr 2016

European Biotech teams up with US Navy to engineer Military Materials

Evolva will join the US Navy to make new materials with its biosynthetic molecules – which could make it into aircrafts and ships. Evolva is a Synthetic biology Biotech headquartered near Basel (Switzerland), but with offices and R&D also in Denmark. It has developed its yeast platform to produce high-value chemicals via fermentation. So far, […]

April 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

jens nielsen novozymes chalmers nordisk novo cell factories

News and Trends 18 Feb 2016

This Pioneering Systems Biology Professor Received a €400K Prize from Novozymes

Jens Nielsen pioneered Systems Biology in Europe. His research efforts focus on transferring science research to industrial applications – to create a society independent of fossil fuels. He has now been awarded Novozymes Prize. Nielsen, a professor at Chalmers University of Technology in Gothenburg (Sweden), literally co-wrote the book on Metabolic Engineering back in 1998. During this period he […]

February 18, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 12 Jan 2016

10 Hot European Biotechs to watch in 2016

Looking forward to 2016, I wondered which Biotechs I would watch closely. Here’s my list (which is not meant to be extensive and is in no particular order): 1. Immunocore – Oxford, UK Immunocore is developing TCR-based immuno-oncology treatments and has raised nearly €300M ($320M) in its last round of private fundraising – a pure anomaly […]

January 12, 2016 - 6 minutesmins - By Philip Hemme

News and Trends 19 Oct 2015

Synbio Perfumery: Making Smells and Flavors with Microbes

Isobionics is a biotech from the Netherlands that specializes in synthetic bio-production of natural essential oils and flavorings for use in the food, perfume and detergent industry. On the other hand, Evolva, from Basel, are estimated to produce up to $500M worth of synthetic vanilla essence for the industry each year. Using bacteria and yeast […]

October 19, 2015 - 4 minutesmins - By Dani Bancroft

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us